{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:21:39Z","timestamp":1786990899216,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003947","name":"Universidad Nacional de La Plata","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ijpharm.2019.118575","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T11:10:31Z","timestamp":1564139431000},"page":"118575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Hybrid Ofloxacin\/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties"],"prefix":"10.1016","volume":"569","author":[{"given":"B.","family":"Rodenak-Kladniew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Scioli Montoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Sbaraglini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Di Ianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Talevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.A.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.R.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Islan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2019.118575_b0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41522-017-0035-0","article-title":"Staphylococcus aureus interaction with Pseudomonas aeruginosa biofilm enhances tobramycin resistance","volume":"3","author":"Beaudoin","year":"2017","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.ijpharm.2019.118575_b0010","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1128\/AAC.00045-11","article-title":"Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo","volume":"55","author":"Brackman","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2019.118575_b0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.addr.2007.04.013","article-title":"Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering","volume":"59","author":"Bunjes","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2019.118575_b0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(96)04822-3","article-title":"Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles","volume":"148","author":"Cavalli","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0732-8893(92)90038-U","article-title":"A comparison of antimicrobial activity of ofloxacin, l-ofloxacin, and other oral agents for respiratory pathogens","volume":"15","author":"Cherubin","year":"1992","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2019.118575_b0030","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1039\/b812146j","article-title":"Bacterial swarming: a model system for studying dynamic self-assembly","volume":"5","author":"Copeland","year":"2009","journal-title":"Soft Matter"},{"key":"10.1016\/j.ijpharm.2019.118575_b0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jfoodeng.2013.11.027","article-title":"Encapsulation of eugenol rich clove extract in solid lipid carriers","volume":"127","author":"Cort\u00e9s-Rojas","year":"2014","journal-title":"J. Food Eng."},{"key":"10.1016\/j.ijpharm.2019.118575_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6509184","article-title":"Interaction of solid lipid nanoparticles and specific proteins of the corona studied by surface plasmon resonance","volume":"2017","author":"Di Ianni","year":"2017","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ijpharm.2019.118575_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2014.02.005","article-title":"Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers \u2013 a systematic review of in vitro data","volume":"87","author":"Doktorovova","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1872210511307010041","article-title":"Nanostructured lipid carriers (NLCs) for drug delivery and targeting","volume":"7","author":"Fang","year":"2012","journal-title":"Recent Pat. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2019.118575_b0055","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1021\/bm015548s","article-title":"Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH","volume":"2","author":"Fang","year":"2001","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2019.118575_b0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/1759-7714.12508","article-title":"Tumor suppressive roles of eugenol in human lung cancer cells","volume":"9","author":"Fangjun","year":"2018","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.ijpharm.2019.118575_b0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1152\/jappl.2000.89.2.672","article-title":"Relationship of interstitial fluid volume to alveolar fluid clearance in mice: ventilated vs. in situ studies","volume":"89","author":"Fukuda","year":"2000","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijpharm.2019.118575_b0070","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/AAC.44.9.2458-2464.2000","article-title":"Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria","volume":"44","author":"Furneri","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2019.118575_b0075","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2217\/nnm.13.33","article-title":"Targeting of eugenol-loaded solid lipid nanoparticles to the epidermal layer of human skin","volume":"9","author":"Garg","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2019.118575_b0080","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1166\/jbn.2016.2313","article-title":"Intranasal administration of chitosan-coated nanostructured lipid carriers loaded with GDNF improves behavioral and histological recovery in a partial lesion model of Parkinson\u2019s disease","volume":"12","author":"Gartziandia","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2019.118575_b0085","doi-asserted-by":"crossref","first-page":"45290","DOI":"10.1039\/C6RA05574E","article-title":"Chitosan-coated liposomes encapsulating curcumin: study of lipid-polysaccharide interactions and nanovesicle behavior","volume":"6","author":"Hasan","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpharm.2019.118575_b0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2591.2006.01091.x","article-title":"Mechanisms of cytotoxicity of eugenol in human osteoblastic cells in vitro","volume":"39","author":"Ho","year":"2006","journal-title":"Int. Endod. J."},{"key":"10.1016\/j.ijpharm.2019.118575_b0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2008.04.009","article-title":"Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis","volume":"129","author":"Hwang","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2019.118575_b0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.colsurfb.2016.03.040","article-title":"Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization","volume":"143","author":"Islan","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2019.118575_b0105","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1039\/C6TB03366K","article-title":"Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: physicochemical characterization and in vivo targeted delivery to the lungs","volume":"5","author":"Islan","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijpharm.2019.118575_b0110","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.2174\/1381612823666171115110639","article-title":"Development and tailoring of hybrid lipid nanocarriers","volume":"23","author":"Islan","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijpharm.2019.118575_b0115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/CBI20100118","article-title":"Apoptotic effect of eugenol in human colon cancer cell lines","volume":"35","author":"Jaganathan","year":"2011","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ijpharm.2019.118575_b0120","first-page":"147","article-title":"Application of stimuli-responsive chitosan micelles for improved therapeutic efficiency of anticancer agents","volume":"29","author":"Jeong","year":"2018","journal-title":"Appl. Chem. Eng."},{"key":"10.1016\/j.ijpharm.2019.118575_b0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.carbpol.2006.04.008","article-title":"Preparation of polymeric micelles based on chitosan bearing a small amount of highly hydrophobic groups","volume":"66","author":"Jiang","year":"2006","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2019.118575_b0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/clpt.2010.286","article-title":"Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000\u20132009","volume":"89","author":"Kaitin","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2019.118575_b0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejps.2008.02.008","article-title":"A hand-held apparatus for \u201cnose-only\u201d exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages","volume":"34","author":"Kaur","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.118575_b0140","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1128\/AAC.00042-11","article-title":"Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance","volume":"55","author":"Kim","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2019.118575_b0145","article-title":"A critical analysis of calcium carbonate mesocrystals","volume":"5","author":"Kim","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpharm.2019.118575_b0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2010.12.036","article-title":"Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure","volume":"406","author":"Kovacevic","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.resp.2018.07.001","article-title":"The anti-inflammatory and anti-oxidative actions of eugenol improve lipopolysaccharide-induced lung injury","volume":"259","author":"Magalh\u00e3es","year":"2019","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.ijpharm.2019.118575_b0160","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijpharm.2016.12.026","article-title":"Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor","volume":"517","author":"Makled","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0165","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/1040841X.2017.1295225","article-title":"Antimicrobial activity of eugenol and essential oils containing eugenol: a mechanistic viewpoint","volume":"6","author":"Marchese","year":"2017","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.ijpharm.2019.118575_b0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tvjl.2005.07.010","article-title":"Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals","volume":"172","author":"Martinez","year":"2006","journal-title":"Vet. J."},{"key":"10.1016\/j.ijpharm.2019.118575_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2007.04.012","article-title":"Nanostructured lipid carriers (NLC) in cosmetic dermal products","author":"M\u00fcller","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2019.118575_b0180","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/toxsci\/kfm240","article-title":"Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique","volume":"101","author":"Murdock","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ijpharm.2019.118575_b0185","doi-asserted-by":"crossref","DOI":"10.15171\/apb.2015.043","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: structure preparation and application","author":"Naseri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2019.118575_b0195","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.foodres.2009.06.006","article-title":"Physicochemical investigation and molecular modeling of cyclodextrin complexation mechanism with eugenol","volume":"42","author":"Nuchuchua","year":"2009","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ijpharm.2019.118575_b0200","first-page":"670","article-title":"Analytical profile of the fluoroquinolone antibacterials","volume":"7","author":"Okeri","year":"2008","journal-title":"Afr. J. Biotechnol."},{"key":"10.1016\/j.ijpharm.2019.118575_b0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0378-5173(97)00196-8","article-title":"Improved dissolution of ofloxacin via solid dispersion","volume":"156","author":"Okonogi","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0210","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijpharm.2012.10.044","article-title":"Chitosan microspheres as an alveolar macrophage delivery system of ofloxacin via pulmonary inhalation","volume":"441","author":"Park","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001163","article-title":"The Influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy","volume":"5","author":"Parry","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpharm.2019.118575_b0220","first-page":"153","article-title":"Eugenol-a review","volume":"6","author":"Pavithra","year":"2014","journal-title":"J. Pharm. Sci. Res"},{"key":"10.1016\/j.ijpharm.2019.118575_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","volume":"392","author":"Pilcer","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0230","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1016\/j.carres.2004.09.007","article-title":"Preparation and antibacterial activity of chitosan nanoparticles","volume":"339","author":"Qi","year":"2004","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ijpharm.2019.118575_b0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpharm.2017.01.013","article-title":"Synergistic antimicrobial potential of essential oils in combination with nanoparticles: emerging trends and future perspectives","volume":"519","author":"Rai","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0240","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpha.2016.11.001","article-title":"Taste masking of ofloxacin and formation of interpenetrating polymer network beads for sustained release","volume":"7","author":"Rajesh","year":"2017","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ijpharm.2019.118575_b0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.colsurfb.2011.11.051","article-title":"Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin","volume":"93","author":"Ridolfi","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2019.118575_b0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.colsurfb.2017.03.021","article-title":"Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy","volume":"154","author":"Rodenak-Kladniew","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2019.118575_b0255","first-page":"382","article-title":"FTIR and Raman Spectroscopic investigations of Ofloxacin\/Carbopol940 mucoadhesive suspension","volume":"4","author":"Sahoo","year":"2012","journal-title":"Int. J. PharmTech Res."},{"key":"10.1016\/j.ijpharm.2019.118575_b0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejpb.2016.10.010","article-title":"Chitosan-coupled solid lipid nanoparticles: tuning nanostructure and mucoadhesion","volume":"110","author":"Sandri","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.colsurfb.2018.03.052","article-title":"Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: physicochemical characterization and in vitro\/in vivo evaluation","volume":"167","author":"Scioli Montoto","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2019.118575_b0270","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.carbpol.2018.03.101","article-title":"Eugenol-chitosan nanoemulsions by ultrasound-mediated emulsification: formulation, characterization and antimicrobial activity","volume":"193","author":"Shao","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2019.118575_b0275","series-title":"2010 International Conference on E-Product E-Service and E-Entertainment, ICEEE2010","article-title":"Spectrum characteristic and variation mechanism of ofloxacin under different acid-basic conditions","author":"Shi","year":"2010"},{"key":"10.1016\/j.ijpharm.2019.118575_b0280","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/00914037.2010.483219","article-title":"Preparation, antibacterial and physicochemical behavior of chitosan\/ofloxacin complexes","volume":"59","author":"Singh","year":"2010","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.ijpharm.2019.118575_b0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2015.11.042","article-title":"Synergistic interactions between doxycycline and terpenic components of essential oils encapsulated within lipid nanocapsules against gram negative bacteria","volume":"498","author":"Valcourt","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0290","first-page":"1","article-title":"Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery","volume":"2013","author":"Varshosaz","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ijpharm.2019.118575_b0295","doi-asserted-by":"crossref","first-page":"10467","DOI":"10.1073\/pnas.1710235114","article-title":"Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms","volume":"114","author":"Wang","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2019.118575_b0300","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejpb.2013.08.013","article-title":"Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art","volume":"86","author":"Weber","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0305","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1021\/bm700453x","article-title":"Chitosan as a lipid binder: a Langmuir monolayer study of chitosan-lipid interactions","volume":"8","author":"Wydro","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2019.118575_b0310","first-page":"547","article-title":"Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles","volume":"6","author":"Xie","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2019.118575_b0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijpharm.2017.08.066","article-title":"A novel and organic solvent-free preparation of solid lipid nanoparticles using natural biopolymers as emulsifier and stabilizer","volume":"531","author":"Xue","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.118575_b0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/IRJPAC\/2016\/23315","article-title":"Chromium (VI) ions removal from tannery effluent using chitosan-microcrystalline cellulose composite as adsorbent","volume":"10","author":"Yasmeen","year":"2016","journal-title":"Int. Res. J. Pure Appl. Chem."},{"key":"10.1016\/j.ijpharm.2019.118575_b0325","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10529-012-1126-x","article-title":"Eugenol inhibits quorum sensing at sub-inhibitory concentrations","volume":"35","author":"Zhou","year":"2013","journal-title":"Biotechnol. Lett."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517319306192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517319306192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:39:01Z","timestamp":1759916341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517319306192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":64,"alternative-id":["S0378517319306192"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118575","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hybrid Ofloxacin\/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118575"}}